"10.1371_journal.pone.0122558","plos one","2015-04-13T00:00:00Z","Nerea Bartolom√©; Sergi Segarra; Marta Artieda; Olga Francino; Elisenda S√°nchez; Magdalena Szczypiorska; Joaquim Casellas; Diego Tejedor; Joaqu√≠n Cerdeira; Antonio Mart√≠nez; Alfonso Velasco; Armand S√°nchez","Progenika Biopharma SA, a Grifols Company, Derio, Bizkaia, Spain; Bioib√©rica SA, Barcelona, Spain; Servei Veterinari de Gen√®tica Molecular, Departament de Ci√®ncia Animal i dels Aliments, Facultat de Veterin√†ria, Universitat Aut√≤noma de Barcelona, Barcelona, Spain; Centro Veterinario Aluche Las √Åguilas, Madrid, Spain","Conceived and designed the experiments: AV AM AS OF DT MA NB J. Cerdeira. Performed the experiments: ES MS NB J. Cerdeira. Analyzed the data: MA NB OF DT ES J. Cerdeira J. Casellas. Contributed reagents/materials/analysis tools: AM AS AV. Wrote the paper: NB MA SS OF AS.","The work presented in this report is the subject of a pending patent filed by Biobierica SA and Progenika SA (Title: Markers for joint dysplasia, osteoarthritis and conditions secondary thereto; Published as EP 2619319 A2 and US 2013-0263294 A1). NB, MA, DT, AM, ES, OF, AV and AS are listed as inventors in the patent file. A product has been developed by Progenika SA and Bioiberica SA (Dysgen test for Labrador retrievers commercially available). NB, MS, MA, AM and DT are currently employees of Progenika Biopharma SA. AV and SS are employed by Bioiberica SA whose company funded this study, as Head of Veterinary Division and R&D Veterinary Manager, respectively. JC received honoraria from Bioib√©rica SA for consultancy and for performing the analysis of the pedigrees. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2015","04","Nerea Bartolom√©","NB√",12,TRUE,8,4,6,5,TRUE,TRUE,FALSE,0,NA,FALSE
